Pfizer & Wyeth: Is Mega Merger A Strategic Move Or Desperate Play?

A mega merger combining Pfizer and Wyeth would create a behemoth with combined sales of over $70 billion, build Pfizer's experience base in biotech, give Pfizer the substantial vaccine business it has been searching for and create billions in cost savings opportunities

More from Archive

More from Pink Sheet